← Back to Analyst Consensus 
RNAC Buy
Cartesian Therapeutics, Inc.
Current Price —
Implied Upside —
Analysts 13
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 2 reiterations from 2 firms
Next Earnings
Nov 4, 2026 (9 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 30, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Sep 29, 2026 | Needham | reiterate | Buy → Buy | — | 50% |
| Aug 18, 2026 | Wedbush | reiterate | Outperform → Outperform | — | 58% |
| Jun 10, 2026 | Wedbush | reiterate | Outperform → Outperform | — | 58% |
| Jun 9, 2026 | Needham | reiterate | Buy → Buy | — | 50% |
| Jun 9, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| May 27, 2026 | Wedbush | reiterate | Outperform → Outperform | — | 58% |
| May 26, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| May 12, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| May 1, 2026 | Wedbush | reiterate | Outperform → Outperform | — | 58% |
| Mar 10, 2026 | Wedbush | reiterate | Outperform → Outperform | — | 58% |
| Mar 9, 2026 | Cantor Fitzgerald | upgrade | Neutral → Overweight | — | 50% |
| Mar 9, 2026 | Needham | reiterate | Buy → Buy | — | 50% |
| Jan 9, 2026 | Needham | maintain | Buy → Buy | $42 | 50% |
| Nov 19, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $30 | 44% |
| Nov 14, 2025 | BTIG | maintain | Buy → Buy | $44 | 52% |
| Jul 9, 2025 | Wedbush | initiate | — → Outperform | $38 | 58% |
| May 8, 2025 | Needham | maintain | Buy → Buy | $40 | 50% |
| Apr 9, 2025 | Needham | reiterate | Buy → Buy | $41 | 50% |
| Apr 9, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $40 | 44% |
| Mar 14, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $40 | 44% |
| Mar 13, 2025 | Needham | reiterate | Buy → Buy | $41 | 50% |
| Jan 28, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $45 | 44% |
| Jan 27, 2025 | Needham | reiterate | Buy → Buy | $41 | 50% |
| Jan 13, 2025 | Needham | reiterate | Buy → Buy | $41 | 50% |
| Dec 19, 2024 | BTIG | initiate | — → Buy | $42 | 52% |
| Dec 4, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $45 | 44% |
| Dec 3, 2024 | Needham | reiterate | Buy → Buy | $41 | 50% |
| Nov 25, 2024 | Needham | reiterate | Buy → Buy | $41 | 50% |
| Nov 8, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $41 | 44% |
| Nov 8, 2024 | Needham | reiterate | Buy → Buy | $41 | 50% |
| Oct 16, 2024 | Needham | reiterate | Buy → Buy | $41 | 50% |
| Sep 13, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $45 | 44% |
| Sep 4, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $45 | 44% |
| Aug 12, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $45 | 44% |
| Aug 9, 2024 | Needham | maintain | Buy → Buy | $41 | 50% |
| Aug 6, 2024 | TD Cowen | initiate | — → Buy | $0 | 54% |
| Jul 8, 2024 | Needham | reiterate | Buy → Buy | $42 | 50% |
| Jul 3, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $49 | 44% |
| Jul 3, 2024 | Canaccord Genuity | maintain | Buy → Buy | $43 | 48% |
| Jul 2, 2024 | Oppenheimer | downgrade | Outperform → Peer Perform | $0 | 52% |
| Jul 1, 2024 | Needham | reiterate | Buy → Buy | $42 | 50% |
| Jun 24, 2024 | Oppenheimer | reiterate | Outperform → Outperform | $50 | 52% |
| Jun 17, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $54 | 44% |
| Jun 14, 2024 | Oppenheimer | maintain | Outperform → Outperform | $50 | 52% |
| Jun 4, 2024 | Oppenheimer | initiate | — → Outperform | $50 | 52% |
| May 24, 2024 | Mizuho | initiate | — → Buy | $40 | 52% |
| May 23, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $54 | 44% |
| May 9, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $54 | 44% |
| May 8, 2024 | Needham | reiterate | Buy → Buy | $42 | 50% |
Price Target Trend
Apr 6, 2026 Oct 26, 2026
EPS Estimates
+1q —
0q —
+1y —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days